Who should be taking weight-loss drugs? Doctors share best candidates

Who should be taking weight-loss drugs? Doctors share best candidates

Benefits of GLP-1 medications extend beyond diabetes and obesity, new research shows

Most adults who have obesity are good candidates for these medications, doctors told Fox News Digital. (iStock)

GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — are intended to treat type 2 diabetes and obesity. (Michael Siluk/UCG/Universal Images Group via Getty Images)

"The most important group that we really want to address are the patients who have obesity alongside other comorbid conditions, such as type 2 diabetes, hypertension, obstructive sleep apnea and significant osteoarthritis," a doctor told Fox News Digital. (iStock)

Those interested in weight-loss medications should consult with a physician to explore potential benefits and risks. (iStock)